Contract facts
Small businessThis Firm Fixed Price Purchase Order Is Awarded for Centralized Information Technology System for the NIH Blueprint Neu… is a federal Small business award for National Institutes Of Health Olao held by Collaborative Drug Discovery, Inc. Estimated value $525K ($525K obligated). Current period of performance ends Jun 14, 2027. Last award drew 2 bidders. Place of performance: BURLINGAME CA. Related solicitation CS-122768-SB.
This firm fixed price purchase order is awarded for centralized information technology system for the nih blueprint neurotherapeutics network to collaborative drug discovery inc:1187446 in the amount of $525,000.00. quote# jm-06022026-01
Recompete timing
PublicCurrent PoP ends Jun 14, 2027 (234 days remaining). Agencies typically plan 12–18 months ahead — at 7.7 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N98026P00759? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordCollaborative Drug Discovery, Inc — $2.2M obligated across 5 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N98026P00759?
75N98026P00759 (This firm fixed price purchase order) is a National Institutes Of Health Olao award with a potential value of $525K, currently held by Collaborative Drug Discovery, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N98026P00759?
National Institutes Of Health Olao awarded 75N98026P00759 to Collaborative Drug Discovery, Inc (potential $525K).
Who is the incumbent on 75N98026P00759?
Collaborative Drug Discovery, Inc is the incumbent with $2.2M across 5 related awards in SCOUT’s public footprint. The current period of performance ends Jun 14, 2027.
When does Collaborative Drug Discovery, Inc’s 75N98026P00759 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N98026P00759? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.